LARIMAR THERAPEUTICS, INC.

Transcripts Larimar Therapeutics, Inc.

Equities

LRMR

US5171251003

Real-time Estimate Cboe BZX Other stock markets 15:11:02 09/05/2024 BST			5-day change	1st Jan Change
7.865 ^USD	-0.69%		+1.18%	+69.23%

03-19	North American Morning Briefing : Stock Futures -2-	DJ
03-14	Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Larimar Therapeutics, Inc. - Special Call	02-12
Transcript : Larimar Therapeutics, Inc. - Special Call	25/07/23
Transcript : Larimar Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023	15/05/23
Transcript : Larimar Therapeutics, Inc. - Special Call	14/09/22
Transcript : Larimar Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 05:00 PM	09/09/21
Transcript : Larimar Therapeutics, Inc. - Special Call	11/05/21
Transcript : Chondrial Therapeutics, Inc., Zafgen, Inc. - M&A Call	18/12/19
Transcript : Zafgen, Inc., Q4 2018 Earnings Call, Mar 11, 2019	11/03/19
Transcript : Zafgen, Inc., Q3 2018 Earnings Call, Nov 07, 2018	07/11/18
Transcript : Zafgen, Inc., Q2 2018 Earnings Call, Aug 07, 2018	07/08/18
Transcript : Zafgen, Inc. - Special Call	25/06/18
Transcript : Zafgen, Inc. Presents at 43rd annual Deutsche Bank Healthcare Conference, May-09-2018 10:00 AM	09/05/18
Transcript : Zafgen, Inc., Q1 2018 Earnings Call, May 08, 2018	08/05/18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer